<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Nephrol</journal-id><journal-id journal-id-type="publisher-id">WJN</journal-id><journal-title-group><journal-title>World Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2220-6124</issn><publisher><publisher-name>Baishideng Publishing Group Inc</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27872833</article-id><article-id pub-id-type="pmc">5099597</article-id><article-id pub-id-type="other">jWJN.v5.i6.pg517</article-id><article-id pub-id-type="doi">10.5527/wjn.v5.i6.517</article-id><article-categories><subj-group subj-group-type="heading"><subject>Observational Study</subject></subj-group></article-categories><title-group><article-title>Impact of renal transplantation on cardiac morphological and functional characteristics in children and adults</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>El-Khashab</surname><given-names>Sahier Omar</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mohamed</surname><given-names>Eman El-Sayed</given-names></name></contrib><contrib contrib-type="author"><name><surname>Soliman</surname><given-names>Mahmoud A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kassem</surname><given-names>Hussein Heshmat</given-names></name></contrib><contrib contrib-type="author"><name><surname>Soliman</surname><given-names>Amin Roshdy</given-names></name></contrib><aff>Sahier Omar El-Khashab, Eman El-Sayed Mohamed, Amin Roshdy Soliman, Department of Nephrology, Kasr Al-Ainy Cairo University, Cairo 11451, Egypt</aff><aff>Mahmoud A Soliman, Department of Medicine, Kasr Al-Ainy Cairo University, Cairo 11451, Egypt</aff><aff>Hussein Heshmat Kassem, Department of Cardiology, Kasr Al-Ainy Cairo University, Cairo 11451, Egypt</aff></contrib-group><author-notes><fn><p>Author contributions: All the authors contributed to the paper.</p><p>Correspondence to: Amin Roshdy Soliman, MD, PhD, FASN, Professor of Medicine and Nephrology, Department of Nephrology, Kasr Al-Ainy Cairo University, 41 Manial street, Cairo 11451, Egypt. <email>aminroshdy@yahoo.com</email></p><p>Telephone: +20-2-22912555 Fax: +20-2-24194949</p></fn></author-notes><pub-date pub-type="ppub"><day>6</day><month>11</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>6</day><month>11</month><year>2016</year></pub-date><volume>5</volume><issue>6</issue><fpage>517</fpage><lpage>523</lpage><history><date date-type="received"><day>12</day><month>6</month><year>2016</year></date><date date-type="rev-recd"><day>29</day><month>8</month><year>2016</year></date><date date-type="accepted"><day>13</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9;The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.</license-p></license></permissions><abstract><sec><title>AIM</title><p>To compare the effects of renal transplantation on cardiac functions in children and adults.</p></sec><sec><title>METHODS</title><p>One hundred and ten patients attending the nephrology outpatient clinic were enrolled in this study and were divided into six groups. The first two groups consisted each of 30 renal transplant patients who had a successful renal transplantation more than six months, but less than one year. Group I were less than 18 years and group II were more than 18 years. The third and fourth groups, each were 20 chronic renal failure patients on regular hemodialysis. Again, group III were less than 18 years and group IV were more than 18 years. Group V and VI (The control Groups) consisted each of 5 subjects below and above 18 years of age, respectively with normal kidney functions. All patients were subjected to history and examination. The kidney functions and the hemoglobin were analyzed. After obtaining informed consent, echocardiography was done to all patients.</p></sec><sec><title>RESULTS</title><p>There was a statistically significant improvement (<italic>P</italic> &#x0003c; 0.0001) in all cardiac parameters. A regression in left ventricular end diastolic volume (LVED) both in children (4.7 &#x000b1; 0.8 to 4.2 &#x000b1; 0.5) and in adults (5.9 &#x000b1; 0.7 to 4.9 &#x000b1; 0.6) were found. There was a regression in left ventricular end systolic volume (LVES) both in children (3.1 &#x000b1; 0.6 to 2.4 &#x000b1; 0.4) and in adults (4.1 &#x000b1; 0.9 to 3.1 &#x000b1; 0.5). Fractional shortening improves both in children (32.6 &#x000b1; 5.3 to 41.7 &#x000b1; 7.6) and in adults (29.0 &#x000b1; 6.6 to 36.5 &#x000b1; 4.1). The improvement in ejection fraction (EF) was higher in children (59.7 &#x000b1; 7.0 to 71.9 &#x000b1; 6.1) than in adults (52.0 &#x000b1; 12.5 to 64.8 &#x000b1; 5.9). However, this degree of improvement (in children: 12.2 &#x000b1; 5.1) did not show statistical difference (<italic>P</italic>-value 0.8), when compared to adults (12.7 &#x000b1; 9.8).</p></sec><sec><title>CONCLUSION</title><p>After renal transplantation cardiac functions and morphology (EF/LVED/LVES) do improve markedly and rapidly in both children and adults.</p></sec></abstract><kwd-group><kwd>Echocardiography chronic renal disease</kwd><kwd>Renal transplantation</kwd><kwd>Cardiac problems</kwd></kwd-group></article-meta></front><body><p><bold>Core tip:</bold> Cardiac functions do improve in chronic kidney disease patients after renal transplantation. This improvement is evident even in the early post-transplant period. In our study, we concluded that this improvement is even more marked in children. Renal transplantation in children with end-stage rend disease should, therefore, be encouraged.</p><sec><title>INTRODUCTION</title><p>Chronic kidney disease (CKD) affects almost 13% of the Unites States citizens and is definitely related to increased risk of cardiovascular (CV) diseases. After renal replacement therapy (RRT) became available, it became evident that the cause of death of patients with advanced CKD was more likely related to CV compromise[<xref rid="B1" ref-type="bibr">1</xref>].</p><p>In hemodialysis (HD) or peritoneal dialysis patients, Coronary artery disease (CAD) prevalence is estimated at 40% with a 9% annual CV mortality[<xref rid="B2" ref-type="bibr">2</xref>]. Renal transplant recipients (RTRs) have a lower CAD prevalence (15%) with an annual CV mortality of 0.54%[<xref rid="B3" ref-type="bibr">3</xref>]. Left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular disease (CVD) related to death in patients on RRT[<xref rid="B4" ref-type="bibr">4</xref>]. In a prospective echocardiographic study, patients with renal insufficiency and clearances of 25 to 50 mL/min and less than 25 mL/min, the prevalence of LVH was 31% and 45% respectively[<xref rid="B5" ref-type="bibr">5</xref>]. Echocardiographic studies of patients on dialysis have revealed severe systolic dysfunction [left ventricular (LV) ejection fraction (EF) of &#x02264; 25%] in 15% of patients; with 74% of patients having LVH and 32% of patients demonstrating LV dilatation[<xref rid="B6" ref-type="bibr">6</xref>]. Although increased awareness of CVD has resulted in a reduction in related deaths over time, yet still they remain the leading mortality cause of in RTRs[<xref rid="B7" ref-type="bibr">7</xref>]. The American Society for Transplantation guidelines has recommended pretransplant risk stratification and noninvasive stress testing for candidates at high cardiac risk[<xref rid="B8" ref-type="bibr">8</xref>].</p><p>Although cardiovascular problems in adults were thoroughly investigated, yet much less work has been done in children and adolescents with end-stage rend disease (ESRD) whether before or after renal transplantation. Cardiac changes are believed to be less prevalent in children compared to adults with chronic renal failure (CRF). However, no recent studies discussing their frequency are available. Long-term prognosis of cardiac morphological changes in children with CRF and after renal transplantation is largely unknown. When the pediatric mortality in RRT patients in Europe between 1987 and 1990 was investigated, a CV cause of death was identified in 51% of dialysis and in 37% of transplanted subjects[<xref rid="B9" ref-type="bibr">9</xref>]. Cardiac disease is known to be the second most common cause of mortality in children after infection and is the leading cause of death in young adults who have undergone renal transplantation[<xref rid="B10" ref-type="bibr">10</xref>]. Although CV mortality is relatively high in pediatric RTRs, it does not always follow that the same risk factors as in adults[<xref rid="B11" ref-type="bibr">11</xref>]. According to Johnstone et al[<xref rid="B12" ref-type="bibr">12</xref>] the most common echocardiographic abnormality in ESRD before renal transplantation is LVH (47.9%). This prevalence is higher in comparison to other studies, <italic>e.g</italic>., in the only large study performed by European Dialysis Transplant Association in children, an incidence of 22% of post-transplant LVH only was found. Mitsnefes et al[<xref rid="B13" ref-type="bibr">13</xref>] found that the prevalence of LVH was 56% among children and adolescents after renal transplantation. Johnstone and his colleagues indicated that LVH was found to be more frequent and severe in children after transplantation; when compared to those on HD or with advanced renal failure[<xref rid="B12" ref-type="bibr">12</xref>]. Alvares et al[<xref rid="B14" ref-type="bibr">14</xref>] found that pretransplant HD resulted in an increased left ventricular mass index (LVMI) in children, especially if dialysis lasted for more than two years. They concluded that although this cardiac hypertrophy was reversible after renal transplantation, children may benefit from an earlier transplantation. Mitsnefes et al[<xref rid="B13" ref-type="bibr">13</xref>] also found that hypertension was a predictor of increased LVMI after transplantation in both children and adolescents and that control of blood pressure might help in preventing LVH progression in RTRs.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><p>To evaluate the impact of renal transplantation on the cardiac morphology and functional characteristics and to study its clinical correlation with renal graft function in children and adults.</p><p>Our work was carried out in the Nephrology department at Cairo University. One hundred and ten patients attending the nephrology outpatient clinic were enrolled in this study and were divided into six groups. The first two groups consisted each of 30 renal transplant patients who had a successful renal transplantation in a period more than six months, but less than one year. Group 1 was less than 18 years, and group 2 was more than 18 years. The third and fourth groups, each were 20 CRF patients on regular hemodialysis (RHD). Group 3 were less than 18 years, and group 4 was more than 18 years. Group 5 and 6 consisted each of 5 subjects below and above 18 years of age, respectively with normal kidney functions.</p><p>All patients underwent full medical history taking and clinical examination. In all cases, we recorded age, body mass index (BMI) and a complete blood count. Patients in group 1 and 2 had their hemoglobin (Hb) measured before and six months after transplantation. Trans-thoracic echocardiography (TTE) was done to all our patients. Again, patients in group 1 and 2 had their TTE done before and six months after transplantation (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic and laboratory data of various groups (mean values)</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><bold>Age in years</bold></td><td rowspan="1" colspan="1"><bold>Male/female</bold></td><td rowspan="1" colspan="1"><bold>BMI (kg/m<sup>2</sup>)</bold></td><td rowspan="1" colspan="1"><bold>Hb pre Tx</bold></td><td rowspan="1" colspan="1"><bold>Creatinine ne post Tx (mg/dL)</bold></td><td rowspan="1" colspan="1"><bold>Hb post Tx (g/dL)</bold></td><td rowspan="1" colspan="1"><bold>Duration of dialysis in years</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Group 1</td><td rowspan="1" colspan="1">9.8 &#x000b1; 3.7</td><td rowspan="1" colspan="1">18/12</td><td rowspan="1" colspan="1">25.8 &#x000b1; 4.4</td><td rowspan="1" colspan="1">6.9 &#x000b1; 1.0</td><td rowspan="1" colspan="1">0.9 &#x000b1; 0.3</td><td rowspan="1" colspan="1">13.9 &#x000b1; 0.9</td><td rowspan="1" colspan="1">0.6 &#x000b1; 0.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Group 2</td><td rowspan="1" colspan="1">26.8 &#x000b1; 5.6</td><td rowspan="1" colspan="1">25/5</td><td rowspan="1" colspan="1">24.7 &#x000b1; 3.1</td><td rowspan="1" colspan="1">6.9 &#x000b1; 1.2</td><td rowspan="1" colspan="1">1.2 &#x000b1; 0.2</td><td rowspan="1" colspan="1">13.3 &#x000b1; 1.9</td><td rowspan="1" colspan="1">0.9 &#x000b1; 0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Group 3</td><td rowspan="1" colspan="1">10.7 &#x000b1; 2.4</td><td rowspan="1" colspan="1">12/8</td><td rowspan="1" colspan="1">28.2 &#x000b1; 9.0</td><td rowspan="1" colspan="1">8.7 &#x000b1; 1.5</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">3.3 &#x000b1; 1.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Group 4</td><td rowspan="1" colspan="1">43.9 &#x000b1; 14.1</td><td rowspan="1" colspan="1">8/12</td><td rowspan="1" colspan="1">22.7 &#x000b1; 5.2</td><td rowspan="1" colspan="1">9.7 &#x000b1; 1.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">8.5 &#x000b1; 4.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Group 5</td><td rowspan="1" colspan="1">12.0 &#x000b1; 1.5</td><td rowspan="1" colspan="1">5 males</td><td rowspan="1" colspan="1">18.0 &#x000b1; 1.5</td><td rowspan="1" colspan="1">14.2 &#x000b1; 0.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Group 6</td><td rowspan="1" colspan="1">30.2 &#x000b1; 3.7</td><td rowspan="1" colspan="1">5 males</td><td rowspan="1" colspan="1">25.7 &#x000b1; 3.8</td><td rowspan="1" colspan="1">13.2 &#x000b1; 1.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>BMI: Body mass index; Hb: Hemoglobin; Tx: Transplantation.</p></fn></table-wrap-foot></table-wrap><p>We excluded patients older than sixty years, patients with ischemic heart diseases, diabetics, liver cirrhosis, chronic obstructive pulmonary disease and those with a high serum creatinine(&#x0003e; 1.5 mg/dL) after renal transplantation.</p><p>SPSS version 9.0 was used to analyze the data. Data was summarized as mean, SD. <italic>t</italic>-test for dependent and independent variables were used for analysis of two quantitative data. One Way ANOVA test was done for analysis of more than two variables, followed by post HOCC test for detection of significance. Pearson correlation was also done. Value was considered significant if &#x0003c; 0.05.</p></sec><sec><title>RESULTS</title><p>The improvement in all cardiac parameters in the renal transplant groups was statistically significant. Left ventricular end diastolic volume (LVED) decreased in children (4.7 &#x000b1; 0.8 to 4.2 &#x000b1; 0.5) and in adults (5.9 &#x000b1; 0.7 to 4.9 &#x000b1; 0.6) after renal transplantation. There was a regression in left ventricular end systolic volume (LVES) both in children (3.1 &#x000b1; 0.6 to 2.4 &#x000b1; 0.4) and in adults (4.1 &#x000b1; 0.9 to 3.1 &#x000b1; 0.5). There was an improvement in fractional shortening (FS) both in children (32.6 &#x000b1; 5.3 to 41.7 &#x000b1; 7.6) and adults (29.0 &#x000b1; 6.6 to 36.5 &#x000b1; 4.1) (Figure <xref ref-type="fig" rid="F1">1</xref>). The improvement in EF was higher in children (59.7 &#x000b1; 7.0 to 71.9 &#x000b1; 6.1) than in adults (52.0 &#x000b1; 12.5 to 64.8 &#x000b1; 5.9). The degree of improvement in pediatrics (12.2 &#x000b1; 5.1), when compared to adults (12.7 &#x000b1; 9.8) did not show statistical difference (Table <xref ref-type="table" rid="T2">2</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Function graft after renal transplant remains the most beneficial renal replacement therapy for children with end-stage rend disease. <sup>a</sup><italic>P</italic>-value is considered significant if &#x0003c; 0.05. LVED: Left ventricular end diastolic volume; EF: Ejection fraction; LVES: Left ventricular end systolic volume; FS: Fractional shortening.</p></caption><graphic xlink:href="WJN-5-517-g001"/></fig><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Echocardiographic data in various groups (mean values)</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><bold>LVED pre Tx</bold></td><td rowspan="1" colspan="1"><bold>LVES pre Tx</bold></td><td rowspan="1" colspan="1"><bold>FS pre Tx</bold></td><td rowspan="1" colspan="1"><bold>EF pre Tx</bold></td><td rowspan="1" colspan="1"><bold>LVED post Tx</bold></td><td rowspan="1" colspan="1"><bold>LVES post Tx</bold></td><td rowspan="1" colspan="1"><bold>FS post Tx</bold></td><td rowspan="1" colspan="1"><bold>EF post Tx</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Group 1</td><td rowspan="1" colspan="1">4.7 &#x000b1; 0.8</td><td rowspan="1" colspan="1">3.1 mm &#x000b1; 0.6 mm</td><td rowspan="1" colspan="1">32.6% &#x000b1; 5.3%</td><td rowspan="1" colspan="1">59.7% &#x000b1; 7.0%</td><td rowspan="1" colspan="1">4.2 mm &#x000b1; 0.5 mm</td><td rowspan="1" colspan="1">2.4 mm &#x000b1; 0.4 mm</td><td rowspan="1" colspan="1">41.7% &#x000b1; 7.6%</td><td rowspan="1" colspan="1">71.9 &#x000b1; 6.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Group 2</td><td rowspan="1" colspan="1">5.9 &#x000b1; 0.7</td><td rowspan="1" colspan="1">4.1 &#x000b1; 0.9</td><td rowspan="1" colspan="1">29.0 &#x000b1; 6.6</td><td rowspan="1" colspan="1">52.0 &#x000b1; 12.5</td><td rowspan="1" colspan="1">4.9 &#x000b1; 0.6</td><td rowspan="1" colspan="1">3.1 &#x000b1; 0.5</td><td rowspan="1" colspan="1">36.5 &#x000b1; 4.1</td><td rowspan="1" colspan="1">64.8 &#x000b1; 5.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Group 3</td><td rowspan="1" colspan="1">4.7 &#x000b1; 0.8</td><td rowspan="1" colspan="1">3.2 &#x000b1; 0.6</td><td rowspan="1" colspan="1">30.9 &#x000b1; 5.0</td><td rowspan="1" colspan="1">56.5 &#x000b1; 6.3</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Group 4</td><td rowspan="1" colspan="1">5.6 &#x000b1; 0.8</td><td rowspan="1" colspan="1">4.0 &#x000b1; 1.0</td><td rowspan="1" colspan="1">29.2 &#x000b1; 4.3</td><td rowspan="1" colspan="1">50.2 &#x000b1; 7.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Group 5</td><td rowspan="1" colspan="1">4.2 &#x000b1; 0.4</td><td rowspan="1" colspan="1">LVES 3.0 &#x000b1; 0.5</td><td rowspan="1" colspan="1">41.9 &#x000b1; 2.3</td><td rowspan="1" colspan="1">71.6 &#x000b1; 4.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Group 6</td><td rowspan="1" colspan="1">5.0 &#x000b1; 0.3</td><td rowspan="1" colspan="1">3.1 &#x000b1; 0.6</td><td rowspan="1" colspan="1">38.0 &#x000b1; 1.9</td><td rowspan="1" colspan="1">64.8 &#x000b1; 3.4</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>LVED: Left ventricular end diastolic; LVES: Left ventricular end systolic; FS: Fractional shortening; EF: Ejection fraction; Tx: Transplantation.</p></fn></table-wrap-foot></table-wrap><p>When the data in post-transplant children were compared to those on RHD and normal children, there were statistically significant differences, regarding Hb levels (<italic>P</italic>-value 0.0001), LVED (<italic>P</italic>-value 0.02), LVES (<italic>P</italic>-value 0.0001), FS (<italic>P</italic>-value 0.0001) and EF (<italic>P</italic>-value 0.0001) (Table <xref ref-type="table" rid="T3">3</xref>).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of children data before and after renal transplantation</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Variables</bold></td><td rowspan="1" colspan="1"><bold>Before renal transplantation</bold>
<bold>(mean &#x000b1; SD)</bold></td><td rowspan="1" colspan="1"><bold>After renal transplantation</bold>
<bold>(mean &#x000b1; SD)</bold></td><td rowspan="1" colspan="1"><bold><italic>P</italic>-value</bold>
<bold>(<italic>P</italic>-value is significant if &#x0003c; 0.05)</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Hemoglobin <italic>n</italic> (g/dL)</td><td rowspan="1" colspan="1">6.9 &#x000b1; 1.0</td><td rowspan="1" colspan="1">13.9 &#x000b1; 0.9</td><td rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">LVED (mm)</td><td rowspan="1" colspan="1">4.7 &#x000b1; 0.8</td><td rowspan="1" colspan="1">4.2 &#x000b1; 0.5</td><td rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">LVES (mm)</td><td rowspan="1" colspan="1">3.1 &#x000b1; 0.6</td><td rowspan="1" colspan="1">2.4 &#x000b1; 0.4</td><td rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">FS (%)</td><td rowspan="1" colspan="1">32.6 &#x000b1; 5.3</td><td rowspan="1" colspan="1">41.7 &#x000b1; 7.6</td><td rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">EF (%)</td><td rowspan="1" colspan="1">59.7 &#x000b1; 7.0</td><td rowspan="1" colspan="1">71.9 &#x000b1; 6.1</td><td rowspan="1" colspan="1">0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>LVED: Left ventricular end diastolic; LVES: Left ventricular end systolic; FS: Fractional shortening; EF: Ejection fraction.</p></fn></table-wrap-foot></table-wrap><p>When comparing adults&#x02019; data post renal transplantation to data of adults on RHD and normal adults, there was a statistically significant difference regarding Hb level, LVED, LVES, FS and EF% (<italic>P</italic>-value 0.0001 in all cases) (Table <xref ref-type="table" rid="T4">4</xref>). When correlating the degree of improvement in EF after transplantation to other parameters in both children and adults, there was no statistically significant correlation as regards Hb levels (<italic>P</italic>-value 0.4 in children and 0.1 in adults), age (<italic>P</italic>-value 0.5 <italic>vs</italic> 0.1), duration of dialysis (<italic>P</italic>-value 0.3 <italic>vs</italic> 0.4), BMI (<italic>P</italic>-value 0.8 <italic>vs</italic> 0.7). Comparison of the EF between children and adults showed there was a statistically significant difference, whether before <italic>P</italic>-value 0.005 or after renal transplantation <italic>P</italic>-value 0.0001).</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Comparison of adults&#x02019; data before and after renal transplantation</p></caption><table frame="hsides" rules="groups"><thead align="center"><tr><td align="left" rowspan="1" colspan="1"><bold>Variables</bold></td><td rowspan="1" colspan="1"><bold>Before renal transplantation</bold>
<bold>(mean &#x000b1; SD)</bold></td><td rowspan="1" colspan="1"><bold>After renal transplantation</bold>
<bold>(mean &#x000b1; SD)</bold></td><td rowspan="1" colspan="1"><bold><italic>P</italic>-value</bold>
<bold>(<italic>P</italic>-value is significant if &#x0003c; 0.05)</bold></td></tr></thead><tbody align="center"><tr><td align="left" rowspan="1" colspan="1">Hemoglobin (g/dL)</td><td rowspan="1" colspan="1">6.9 &#x000b1; 1.2</td><td rowspan="1" colspan="1">13.3 &#x000b1; 1.9</td><td rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">LVED (mm)</td><td rowspan="1" colspan="1">5.9 &#x000b1; 0.7</td><td rowspan="1" colspan="1">4.9 &#x000b1; 0.6</td><td rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">LVES (mm)</td><td rowspan="1" colspan="1">4.1 &#x000b1; 0.9</td><td rowspan="1" colspan="1">3.1 &#x000b1; 0.5</td><td rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">FS (%)</td><td rowspan="1" colspan="1">29.0 &#x000b1; 6.6</td><td rowspan="1" colspan="1">36.5 &#x000b1; 4.1</td><td rowspan="1" colspan="1">0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">EF (%)</td><td rowspan="1" colspan="1">52.0 &#x000b1; 12.5</td><td rowspan="1" colspan="1">64.8 &#x000b1; 5.9</td><td rowspan="1" colspan="1">0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>LVED: Left ventricular end diastolic; LVES: Left ventricular end systolic; FS: Fractional shortening; EF: Ejection fraction.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>DISCUSSION</title><p>Compared with the general population, (RTRs) are at a higher risk for morbidity and mortality, largely as a result of (CVD)[<xref rid="B15" ref-type="bibr">15</xref>]. Marked improvements in all cardiac functions are evident after successful renal transplantation. The changes are apparent in the early post-transplant period and continue over time, depending on BP control and renal functions[<xref rid="B16" ref-type="bibr">16</xref>]. The aim of our work is to evaluate the impact of renal transplantation on the cardiac morphological and functional characteristics in children and adults who had renal transplantation and to compare the degree of improvement in children to adults. The study showed that a statistically significant improvement in LVED, LVES and FS and EF occured 6 mo after renal transplantation in the pediatric population. This goes in agreement with the work previously published by El-Husseini et al[<xref rid="B17" ref-type="bibr">17</xref>] where they reported a 56% increase in FS after transplantation; larger than that expected with correction of anemia. Few studies used EF to reflect improvement in cardiac characteristics after renal transplantation, although many used LVH and LVMI.</p><p>In our study, the adult group of renal transplant recipients also showed a statistically significant improvement in LVED, LVES, FS and EF, six months after renal transplantation. Montanaro used LVM and LVMI left compared to the pre-transplantation period to assess cardiac status amelioration. He observed that the prevalence of LVH significantly decreased (78% <italic>vs</italic> 44%, <italic>P</italic> &#x0003c; 0.03). Systolic 24-h BP was the only predictor of LVM and LVMI at two years after transplantation. He concluded that successful renal transplantation produced a regression in LVH and that this beneficial effect depended on a decrease in systolic pressure levels.</p><p>In our work, we attributed the marked improvement in cardiac morphological and functional characteristics after renal transplantation. In to correction of anemia, control of blood pressure, normalization kidney function and reduction of volume overload.</p><p>When comparing pediatric RTRs to those on RHD, there was a statistically significant difference in EF between the two groups (group 1 and 3); with improvement in EF after renal transplantation. These parameters reflect improvement in the degree of left ventricular dilatation and systolic dysfunction in RTR than those on HD. This was in agreement with Chinali et al[<xref rid="B18" ref-type="bibr">18</xref>] Children with CRF have a reduced EF; this was found to be in agreement with work published by Colan et al[<xref rid="B19" ref-type="bibr">19</xref>] who found a markedly reduced EF in children on HD; though many other former studies showed that predialysis or dialysis-dependent CRF children may have a normal or further more a supernormal EF at rest[<xref rid="B20" ref-type="bibr">20</xref>].</p><p>Schrier[<xref rid="B21" ref-type="bibr">21</xref>] reported that in ESRD patients the most common CV abnormalities are systolic dysfunction (30%-60%), diastolic dysfunction (17%), LVH (up to 93%) and LV dilatation (27%). Iqbal et al[<xref rid="B22" ref-type="bibr">22</xref>] 2006 stated that marked beneficial alterations in cardiac function and morphology become apparent as early as three months post renal transplantation.</p><p>Correction of anemia and proper control of BP contribute to the reduction in cardiac ventricular diameters. Long term maintenance of these changes are definitely more in patients with functioning renal graft. Systolic or diastolic hypertension is risk factors for patients and graft survival after renal transplantation. The effect of hypertension on kidney grafts has been attributed to amplification of vascular injury[<xref rid="B23" ref-type="bibr">23</xref>]. Salvatierra et al[<xref rid="B24" ref-type="bibr">24</xref>] reported that in CRF, cardiomyopathy presents by systolic dysfunction, concentric LVH or LVD. Renal transplantation leads to normalization of left ventricular contractility, regression of LVH and improvement of cavity volume.</p><p>A statistically significant increase in Hb level was noted after transplantation in both children and adults; however, when correlating the degree of improvement in Hb with the degree of improvement in EF after transplantation, no statistically significant correlation was found. This was considered to be contrary to Iqbal et al[<xref rid="B25" ref-type="bibr">25</xref>] in 2008, who showed that the reduction in BP with correction of anemia and a decreased in creatinine level influenced the improvements in LV parameters. Foley et al[<xref rid="B6" ref-type="bibr">6</xref>] reported that after renal transplantation, a 17% increase in LVMI (similar to the degree of regression of hypertrophy found on partial correction of anemia by erythropoietin) occurred. LVH regression may be compromised by hypertension, as a clear association was seen between the fall in blood pressure and the fall in LVMI.</p><p>Correction of anemia in CRF patients and RTRs is a an important issue as shown by Walker et al[<xref rid="B26" ref-type="bibr">26</xref>] 2006 who reported that patients with anemia and CRF had elevated risks for CVD. Risks for hospitalization with myocardial infarction was found to be 2-5 times higher in anemic (Hb &#x0003c; 12 g/dL) patients[<xref rid="B27" ref-type="bibr">27</xref>]. The risks for hospitalization for congestive heart failure reduced from a doubling risk at Hb &#x0003c; 10% to a 61% decrease at Hb 15 g/dL after increasing Hb[<xref rid="B28" ref-type="bibr">28</xref>].</p><p>In our study, the comparison of the EF between children and adults showed there was a statistically significant difference, whether before or after renal transplantation. Although the improvement in EF was higher in children than in adults, yet the degree of improvement in children, when compared to the degree of improvement in adults did not show a statistically significant difference. As stated by Salvatierra et al[<xref rid="B29" ref-type="bibr">29</xref>] function graft after renal transplant remains the most beneficial RRT for children with ESRD (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><p>Transplanting children is very challenging. Graft and patient survival were often reported to be less promising in young patients compared with older children and adults, yet the results have recently improved significantly[<xref rid="B30" ref-type="bibr">30</xref>].</p><p>In conclusion, marked improvement in cardiac morphological and functional characteristics occurs after renal transplantation. These findings were found to be more significant in the pediatric population. Renal transplantation is therefore expected to reduce mortality and cardiovascular deaths than dialysis in CRF patients, although, in both groups, survival remains worse than in the general population. Renal transplantation is the treatment of choice for CRF, especially in children and adolescence. A larger number of patients need to be studied with a longer follow-up period up to five years after transplantation with frequent cardiological assessment and proper correlation with anemia correction, BP control, lipid profile correction and detection and management of new-onset diabetes.</p></sec><sec><title>COMMENTS</title><sec><title>Background</title><p>Cardiovascular diseases are the principal causes of morbidity and mortality among adults and children with chronic kidney disease (CKD). After renal transplantation, there is a substantial improvement in cardiac morphology and functions. The early and rapid improvement in cardiac status is even more marked in children.</p></sec><sec><title>Research frontiers</title><p>In Egypt, the number of children with CKD having a renal transplant is increasing. The cardiac problems in children with CKD are among the most common reasons for not choosing renal transplantation for those children. There is a very few English literature documenting the marked improvement in the ejection fraction of Egyptian children especially in comparison to adults. The study hotspot is to emphasize not only the rapid (as early as six months post-transplant) but also the marked improvement in the ejection fraction (EF) in children when compared to adults after have a renal transplant.</p></sec><sec><title>Innovations and breakthroughs</title><p>In recent years the list of contraindications and relative contraindications to renal transplant has been changing. The impaired cardiac function was among the relative contraindications to renal transplantation. The present study shows that there is a marked improvement in EF after renal transplantation both in adults and in children with CKD. Although the improvement is marked and significant in both adults and children yet, the authors&#x02019; study also shows that the improvement in children is even more.</p></sec><sec><title>Applications</title><p>The data in their work suggested that the EF of patients with ESRD improves after renal transplantation, this improvement is marked in children.</p></sec><sec><title>Terminology</title><p>EF is the amount of blood pumped from the heart by heartbeat. It is low in systolic congestive heart failure. It is a similar but different mathematically when compared to stroke volume, which (together with heart rate) measures cardiac output. EF is often determined by echocardiography, in which the volumes of the heart's chambers are measured during the cardiac cycle. EF can then be calculated by dividing the volume ejected by the heart (stroke volume) by the volume of the filled heart (end-diastolic volume). It can also be measured by computed tomogrophy scan, magnetic resonance imaging, ventriculography, gated SPECT and radionuclide angiography scanning.</p></sec><sec><title>Peer-review</title><p>Available papers concerning the comparison between the improvements in cardiac function after renal transplantation in children and adults are rare.</p></sec></sec></body><back><fn-group><fn><p>Manuscript source: Invited manuscript</p></fn><fn><p>Specialty type: Urology and nephrology</p></fn><fn><p>Country of origin: Egypt</p></fn><fn><p>Peer-review report classification</p></fn><fn><p>Grade A (Excellent): 0</p></fn><fn><p>Grade B (Very good): B, B, B</p></fn><fn><p>Grade C (Good): 0</p></fn><fn><p>Grade D (Fair): 0</p></fn><fn><p>Grade E (Poor): 0</p></fn><fn><p>Institutional review board statement: The study was reviewed and approved by the Institutional Review Board at Kasr Al-Ainy Cairo University.</p></fn><fn><p>Informed consent statement: An informed consent has been obtained from all patients at the beginning of the work.</p></fn><fn fn-type="COI-statement"><p>Conflict-of-interest statement: The authors whose names are listed immediately below certify that they have no affiliations with or involvement in any organization or entity with any fi nancial interest (such as honoraria; educational grants; participation in speakers&#x02019; bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.</p></fn><fn><p>Data sharing statement: No data were created so no data are available.</p></fn><fn><p>Peer-review started: June 20, 2016</p></fn><fn><p>First decision: July 11, 2016</p></fn><fn><p>Article in press: September 18, 2016</p></fn><fn><p>P- Reviewer: Ananthasubramaniam K, Nechifor G, Said SAM S- Editor: Qiu S L- Editor: A E- Editor: Li D</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hage</surname><given-names>FG</given-names></name><name><surname>Venkataraman</surname><given-names>R</given-names></name><name><surname>Zoghbi</surname><given-names>GJ</given-names></name><name><surname>Perry</surname><given-names>GJ</given-names></name><name><surname>DeMattos</surname><given-names>AM</given-names></name><name><surname>Iskandrian</surname><given-names>AE</given-names></name></person-group><article-title>The scope of coronary heart disease in patients with chronic kidney disease</article-title><source>J Am Coll Cardiol</source><year>2009</year><volume>53</volume><fpage>2129</fpage><lpage>2140</lpage><pub-id pub-id-type="pmid">19497438</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkovic</surname><given-names>V</given-names></name><name><surname>Ninomiya</surname><given-names>T</given-names></name><name><surname>Arima</surname><given-names>H</given-names></name><name><surname>Gallagher</surname><given-names>M</given-names></name><name><surname>Jardine</surname><given-names>M</given-names></name><name><surname>Cass</surname><given-names>A</given-names></name><name><surname>Neal</surname><given-names>B</given-names></name><name><surname>Macmahon</surname><given-names>S</given-names></name><name><surname>Chalmers</surname><given-names>J</given-names></name></person-group><article-title>Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study</article-title><source>J Am Soc Nephrol</source><year>2007</year><volume>18</volume><fpage>2766</fpage><lpage>2772</lpage><pub-id pub-id-type="pmid">17804673</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mark</surname><given-names>PB</given-names></name><name><surname>Johnston</surname><given-names>N</given-names></name><name><surname>Groenning</surname><given-names>BA</given-names></name><name><surname>Foster</surname><given-names>JE</given-names></name><name><surname>Blyth</surname><given-names>KG</given-names></name><name><surname>Martin</surname><given-names>TN</given-names></name><name><surname>Steedman</surname><given-names>T</given-names></name><name><surname>Dargie</surname><given-names>HJ</given-names></name><name><surname>Jardine</surname><given-names>AG</given-names></name></person-group><article-title>Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging</article-title><source>Kidney Int</source><year>2006</year><volume>69</volume><fpage>1839</fpage><lpage>1845</lpage><pub-id pub-id-type="pmid">16508657</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berl</surname><given-names>T</given-names></name><name><surname>Hunsicker</surname><given-names>LG</given-names></name><name><surname>Lewis</surname><given-names>JB</given-names></name><name><surname>Pfeffer</surname><given-names>MA</given-names></name><name><surname>Porush</surname><given-names>JG</given-names></name><name><surname>Rouleau</surname><given-names>JL</given-names></name><name><surname>Drury</surname><given-names>PL</given-names></name><name><surname>Esmatjes</surname><given-names>E</given-names></name><name><surname>Hricik</surname><given-names>D</given-names></name><name><surname>Pohl</surname><given-names>M</given-names></name><etal/></person-group><article-title>Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial</article-title><source>J Am Soc Nephrol</source><year>2005</year><volume>16</volume><fpage>2170</fpage><lpage>2179</lpage><pub-id pub-id-type="pmid">15930097</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>A</given-names></name></person-group><article-title>Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis</article-title><source>Semin Dial</source><year>2003</year><volume>16</volume><fpage>101</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">12641872</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foley</surname><given-names>RN</given-names></name><name><surname>Parfrey</surname><given-names>PS</given-names></name><name><surname>Harnett</surname><given-names>JD</given-names></name><name><surname>Kent</surname><given-names>GM</given-names></name><name><surname>Martin</surname><given-names>CJ</given-names></name><name><surname>Murray</surname><given-names>DC</given-names></name><name><surname>Barre</surname><given-names>PE</given-names></name></person-group><article-title>Clinical and echocardiographic disease in patients starting end-stage renal disease therapy</article-title><source>Kidney Int</source><year>1995</year><volume>47</volume><fpage>186</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">7731145</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier-Kriesche</surname><given-names>HU</given-names></name><name><surname>Kaplan</surname><given-names>B</given-names></name></person-group><article-title>Death after graft loss: a novel endpoint for renal transplantation</article-title><source>Transplant Proc</source><year>2001</year><volume>33</volume><fpage>3405</fpage><lpage>3406</lpage><pub-id pub-id-type="pmid">11750457</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarnak</surname><given-names>MJ</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Schoolwerth</surname><given-names>AC</given-names></name><name><surname>Coresh</surname><given-names>J</given-names></name><name><surname>Culleton</surname><given-names>B</given-names></name><name><surname>Hamm</surname><given-names>LL</given-names></name><name><surname>McCullough</surname><given-names>PA</given-names></name><name><surname>Kasiske</surname><given-names>BL</given-names></name><name><surname>Kelepouris</surname><given-names>E</given-names></name><name><surname>Klag</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention</article-title><source>Circulation</source><year>2003</year><volume>108</volume><fpage>2154</fpage><lpage>2169</lpage><pub-id pub-id-type="pmid">14581387</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrich</surname><given-names>JH</given-names></name><name><surname>Loirat</surname><given-names>C</given-names></name><name><surname>Brunner</surname><given-names>FP</given-names></name><name><surname>Geerlings</surname><given-names>W</given-names></name><name><surname>Landais</surname><given-names>P</given-names></name><name><surname>Mallick</surname><given-names>NP</given-names></name><name><surname>Margreiter</surname><given-names>R</given-names></name><name><surname>Raine</surname><given-names>AE</given-names></name><name><surname>Selwood</surname><given-names>NH</given-names></name><name><surname>Tufveson</surname><given-names>G</given-names></name></person-group><article-title>Report on management of renal failure in children in Europe, XXII, 1991</article-title><source>Nephrol Dial Transplant</source><year>1992</year><volume>7 Suppl 2</volume><fpage>36</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">1338120</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>SP</given-names></name><name><surname>Craig</surname><given-names>JC</given-names></name></person-group><article-title>Long-term survival of children with end-stage renal disease</article-title><source>N Engl J Med</source><year>2004</year><volume>350</volume><fpage>2654</fpage><lpage>2662</lpage><pub-id pub-id-type="pmid">15215481</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jardine</surname><given-names>AG</given-names></name></person-group><article-title>Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine</article-title><source>Transpl Int</source><year>2005</year><volume>18</volume><fpage>379</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">15773954</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>LM</given-names></name><name><surname>Jones</surname><given-names>CL</given-names></name><name><surname>Grigg</surname><given-names>LE</given-names></name><name><surname>Wilkinson</surname><given-names>JL</given-names></name><name><surname>Walker</surname><given-names>RG</given-names></name><name><surname>Powell</surname><given-names>HR</given-names></name></person-group><article-title>Left ventricular abnormalities in children, adolescents and young adults with renal disease</article-title><source>Kidney Int</source><year>1996</year><volume>50</volume><fpage>998</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">8872976</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsnefes</surname><given-names>MM</given-names></name><name><surname>Schwartz</surname><given-names>SM</given-names></name><name><surname>Daniels</surname><given-names>SR</given-names></name><name><surname>Kimball</surname><given-names>TR</given-names></name><name><surname>Khoury</surname><given-names>P</given-names></name><name><surname>Strife</surname><given-names>CF</given-names></name></person-group><article-title>Changes in left ventricular mass index in children and adolescents after renal transplantation</article-title><source>Pediatr Transplant</source><year>2001</year><volume>5</volume><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">11472607</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvares</surname><given-names>S</given-names></name><name><surname>Mota</surname><given-names>C</given-names></name><name><surname>Soares</surname><given-names>L</given-names></name><name><surname>Henriques</surname><given-names>C</given-names></name><name><surname>Pereira</surname><given-names>E</given-names></name><name><surname>Sarmento</surname><given-names>AM</given-names></name><name><surname>Lima</surname><given-names>CA</given-names></name></person-group><article-title>Cardiac consequences of renal transplantation changes in left ventricular morphology</article-title><source>Rev Port Cardiol</source><year>1998</year><volume>17</volume><fpage>145</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">9587210</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirali</surname><given-names>AC</given-names></name><name><surname>Bia</surname><given-names>MJ</given-names></name></person-group><article-title>Management of cardiovascular disease in renal transplant recipients</article-title><source>Clin J Am Soc Nephrol</source><year>2008</year><volume>3</volume><fpage>491</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">18287250</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peteiro</surname><given-names>J</given-names></name><name><surname>Alvarez</surname><given-names>N</given-names></name><name><surname>Calvi&#x000f1;o</surname><given-names>R</given-names></name><name><surname>Penas</surname><given-names>M</given-names></name><name><surname>Ribera</surname><given-names>F</given-names></name><name><surname>Castro Beiras</surname><given-names>A</given-names></name></person-group><article-title>Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study</article-title><source>Cardiology</source><year>1994</year><volume>85</volume><fpage>273</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">7850816</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Husseini</surname><given-names>AA</given-names></name><name><surname>Sheashaa</surname><given-names>HA</given-names></name><name><surname>Hassan</surname><given-names>NA</given-names></name><name><surname>El-Demerdash</surname><given-names>FM</given-names></name><name><surname>Sobh</surname><given-names>MA</given-names></name><name><surname>Ghoneim</surname><given-names>MA</given-names></name></person-group><article-title>Echocardiographic changes and risk factors for left ventricular hypertrophy in children and adolescents after renal transplantation</article-title><source>Pediatr Transplant</source><year>2004</year><volume>8</volume><fpage>249</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15176962</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chinali</surname><given-names>M</given-names></name><name><surname>de Simone</surname><given-names>G</given-names></name><name><surname>Matteucci</surname><given-names>MC</given-names></name><name><surname>Picca</surname><given-names>S</given-names></name><name><surname>Mastrostefano</surname><given-names>A</given-names></name><name><surname>Anarat</surname><given-names>A</given-names></name><name><surname>Caliskan</surname><given-names>S</given-names></name><name><surname>Jeck</surname><given-names>N</given-names></name><name><surname>Neuhaus</surname><given-names>TJ</given-names></name><name><surname>Peco-Antic</surname><given-names>A</given-names></name><etal/></person-group><article-title>Reduced systolic myocardial function in children with chronic renal insufficiency</article-title><source>J Am Soc Nephrol</source><year>2007</year><volume>18</volume><fpage>593</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">17215443</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colan</surname><given-names>SD</given-names></name><name><surname>Sanders</surname><given-names>SP</given-names></name><name><surname>Ingelfinger</surname><given-names>JR</given-names></name><name><surname>Harmon</surname><given-names>W</given-names></name></person-group><article-title>Left ventricular mechanics and contractile state in children and young adults with end-stage renal disease: effect of dialysis and renal transplantation</article-title><source>J Am Coll Cardiol</source><year>1987</year><volume>10</volume><fpage>1085</fpage><lpage>1094</lpage><pub-id pub-id-type="pmid">3312365</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palcoux</surname><given-names>JB</given-names></name><name><surname>Palcoux</surname><given-names>MC</given-names></name><name><surname>Jouan</surname><given-names>JP</given-names></name><name><surname>Gourgand</surname><given-names>JM</given-names></name><name><surname>Cassagnes</surname><given-names>J</given-names></name><name><surname>Malpuech</surname><given-names>G</given-names></name></person-group><article-title>Echocardiographic patterns in infants and children with chronic renal failure</article-title><source>Int J Pediatr Nephrol</source><year>1982</year><volume>3</volume><fpage>311</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">7166455</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrier</surname><given-names>RW</given-names></name></person-group><article-title>Cardiorenal versus renocardiac syndrome: is there a difference?</article-title><source>Nat Clin Pract Nephrol</source><year>2007</year><volume>3</volume><fpage>637</fpage><pub-id pub-id-type="pmid">18033224</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>MM</given-names></name><name><surname>Banerjee</surname><given-names>SK</given-names></name><name><surname>Rahman</surname><given-names>MH</given-names></name><name><surname>Rashid</surname><given-names>HU</given-names></name></person-group><article-title>Cardiac functional and morphologic changes of renal allograft recipients in the early posttransplant period</article-title><source>Transplant Proc</source><year>2006</year><volume>38</volume><fpage>3527</fpage><lpage>3529</lpage><pub-id pub-id-type="pmid">17175322</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwenger</surname><given-names>V</given-names></name><name><surname>Zeier</surname><given-names>M</given-names></name><name><surname>Ritz</surname><given-names>E</given-names></name></person-group><article-title>Hypertension after renal transplantation</article-title><source>Curr Hypertens Rep</source><year>2001</year><volume>3</volume><fpage>434</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">11551380</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvatierra</surname><given-names>O</given-names></name><name><surname>Alfrey</surname><given-names>E</given-names></name><name><surname>Tanney</surname><given-names>DC</given-names></name><name><surname>Mak</surname><given-names>R</given-names></name><name><surname>Hammer</surname><given-names>GB</given-names></name><name><surname>Krane</surname><given-names>EJ</given-names></name><name><surname>So</surname><given-names>SK</given-names></name><name><surname>Lemley</surname><given-names>K</given-names></name><name><surname>Orlandi</surname><given-names>PD</given-names></name><name><surname>Conley</surname><given-names>SB</given-names></name></person-group><article-title>Superior outcomes in pediatric renal transplantation</article-title><source>Arch Surg</source><year>1997</year><volume>132</volume><fpage>842</fpage><lpage>847; discussion 847-849</lpage><pub-id pub-id-type="pmid">9267267</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>MM</given-names></name><name><surname>Rashid</surname><given-names>HU</given-names></name><name><surname>Banerjee</surname><given-names>SK</given-names></name><name><surname>Rahman</surname><given-names>MH</given-names></name><name><surname>Mohsin</surname><given-names>M</given-names></name></person-group><article-title>Changes in cardiac parameters of renal allograft recipients: a compilation of clinical, laboratory, and echocardiographic observations</article-title><source>Transplant Proc</source><year>2008</year><volume>40</volume><fpage>2327</fpage><lpage>2329</lpage><pub-id pub-id-type="pmid">18790225</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>AM</given-names></name><name><surname>Schneider</surname><given-names>G</given-names></name><name><surname>Yeaw</surname><given-names>J</given-names></name><name><surname>Nordstrom</surname><given-names>B</given-names></name><name><surname>Robbins</surname><given-names>S</given-names></name><name><surname>Pettitt</surname><given-names>D</given-names></name></person-group><article-title>Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine</article-title><source>J Am Soc Nephrol</source><year>2006</year><volume>17</volume><fpage>2293</fpage><lpage>2298</lpage><pub-id pub-id-type="pmid">16837634</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Ahmad</surname><given-names>A</given-names></name><name><surname>Rand</surname><given-names>WM</given-names></name><name><surname>Manjunath</surname><given-names>G</given-names></name><name><surname>Konstam</surname><given-names>MA</given-names></name><name><surname>Salem</surname><given-names>DN</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Sarnak</surname><given-names>MJ</given-names></name></person-group><article-title>Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>38</volume><fpage>955</fpage><lpage>962</lpage><pub-id pub-id-type="pmid">11583864</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>AA</given-names></name><name><surname>Sarnak</surname><given-names>MJ</given-names></name></person-group><article-title>Anemia as a risk factor for cardiovascular disease</article-title><source>Kidney Int Suppl</source><year>2003</year><issue>87</issue><fpage>S32</fpage><lpage>S39</lpage></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvatierra</surname><given-names>O</given-names></name><name><surname>Tanney</surname><given-names>D</given-names></name><name><surname>Mak</surname><given-names>R</given-names></name><name><surname>Alfrey</surname><given-names>E</given-names></name><name><surname>Lemley</surname><given-names>K</given-names></name><name><surname>Mackie</surname><given-names>F</given-names></name><name><surname>So</surname><given-names>S</given-names></name><name><surname>Hammer</surname><given-names>GB</given-names></name><name><surname>Krane</surname><given-names>EJ</given-names></name><name><surname>Conley</surname><given-names>SB</given-names></name></person-group><article-title>Pediatric renal transplantation and its challenges</article-title><source>Transpl Rev</source><year>1997</year><volume>11</volume><fpage>51</fpage><lpage>69</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ettenger</surname><given-names>RB</given-names></name></person-group><article-title>Children are different: the challenges of pediatric renal transplantation</article-title><source>Am J Kidney Dis</source><year>1992</year><volume>20</volume><fpage>668</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">1463001</pub-id></element-citation></ref></ref-list></back></article>